Deregulatory Push & Executive Power

The administration continues expanding executive authority through private offensive-cyber policy, constitutional challenges to NSF programs, federal overrides of state environmental rules, FDA and education changes, and aggressive immigration enforcement. DEA's submission of a final telehealth-prescribing rule for White House review adds a significant pending federal-agency action, although its substance and timing remain unclear. Courts remain the principal constraint.